Linear accelerator radiosurgery for XXXX in and around the cavernous sinus.

@entity1 @entity129 @entity227 @entity1276 @entity5 @entity4 @entity16 @entity4611 @entity1653 @entity50
OBJECTIVE: A retrospective study to evaluate the efficacy and side effects of linear accelerator radiosurgery in the treatment of cavernous @entity50 . METHODS: Between 1993 and 2001, 42 @entity1 with @entity1653 involving the cavernous sinus underwent linear accelerator radiosurgery at our institution. A mean radiation dose of 14 Gy was delivered to the @entity5 margin. The median @entity5 volume was 8.2 cm3 (mean, 8.4 cm3). Median follow-up was 36 months (mean, 38 mo). RESULTS: Control of @entity5 growth was achieved in 97.5% of the @entity1 . There was no mortality or permanent extraocular motor or @entity4611 . Treatment-related complications included new @entity16 in 4.7% and a new @entity227 in 2.8%. Two @entity1 required shunt placement after developing @entity1276 . One @entity1 with symptomatic temporal lobe @entity4 underwent partial excision of the @entity5 . Improvement of existing @entity129 was noted in 29% of affected trigeminal nerves, in 22% of oculomotor nerves, and in 13% of Cranial Nerves IV and VI. CONCLUSION: This study indicates that linear accelerator radiosurgery can achieve a high control rate of @entity1653 involving the cavernous sinus with no mortality and a low incidence of morbidity.
